Israel Hayom is a media organization founded on the belief that the Israeli public deserves better journalism—more balanced, more accurate, and more reliable. Journalism that speaks rather than shouts. Journalism that is trustworthy, objective, and matter-of-fact. A different kind of journalism, offered free of charge. The first print edition was published on July 30, 2007, and in 2010 Israel Hayom became the Israeli newspaper with the highest weekday readership. The newspaper’s publisher is Dr. Miriam Adelson. Its Editor-in-Chief is Omar Lachmanovitch, and its founding editor is Amos Regev. Israel Hayom’s Hebrew and English websites, as well as its Android and iOS applications, provide around-the-clock news coverage, exclusive content, breaking news and updates, analysis and commentary, video, podcasts, and live broadcasts. The digital platforms of Israel Hayom include news and opinion channels covering culture and entertainment, lifestyle, technology, sports, business and consumer affairs, health, military affairs, food, Judaism, tourism, and automobiles. In 2021, a new Hebrew-language website and mobile application were launched to provide users with a fast, up-to-date, secure, and convenient experience. The content of the newspaper’s print edition is also available online through a daily digital edition and can be received via newsletter. “The Israel Hayom Clique,” the publication’s exclusive benefits club, offers website users discounts and special promotions on products and services. Israel Hayom welcomes feedback, criticism, and suggestions for improvement from its readers. You can contact the organization by email at hayom@israelhayom.co.il

Prof. Arnon Ofek

Professor Arnon Ofek serves as deputy director of Sheba Medical Center at Tel Hashomer and is a member of the team that advises Israel's national corona chief

Now, more than ever, we must avoid corona complacency

Despite the success of Israel's vaccination campaign, we still don't know whether those who received the vaccine can infect others. In the meantime, the number of cases is on the rise, and hospitals are reopening their coronavirus wards.

 

Many countries around the world are in awe of the State of Israel's vaccination campaign. In under two weeks, 1 million Israelis have been vaccinated with Pfizer's coronavirus vaccine, and we are now inoculating people a day. As of Jan. 1, Israel is the world leader in the number of vaccines administered for every 100 people, with countries like Britain, the US, and Germany, following not so closely behind. Moreover, many European countries have barely kicked off their vaccination campaigns.

Beyond the Israeli government's extraordinary achievement in bringing over the vaccines, we have risen to the task thanks to the country's strong healthcare system, logistical prowess, ability to respond quickly in emergencies, and most importantly, the enlistment and volunteering spirit of medical staff: nurses who finished their shift and volunteered for another, administrative staff who set up over 200 vaccination centers in record time, pharmacists, and countless others. It is particularly moving to see Holocaust survivors come to Sheba Medical Center for their vaccination, allowing us to express our gratitude to them for establishing the state.

Follow Israel Hayom on Facebook and Twitter

In the midst of the vaccination campaign, we learned of cases where medical workers experiencing muscle pain and chills believed these were merely side effects of the vaccine. These symptoms were in fact an indication they had developed COVID-10, and indeed, those workers tested positive for the virus.

How much protection does the first dose of the vaccine provide? The vaccine is at its most effective around one week after the second dose, or 28 days after the first dose is administered. The first dose triggers a cellular response – antibodies and immune cells that are immune to the virus. The second dose triggers the memory cells and strengthens the body's immune system to something like 95% efficacy.

The vaccine itself does not cause the illness because it does not contain fragments of the virus.

In the 28 days following the administration of the first dose, the body's defenses against the virus grow from around 50% immediately after inoculation to around 95% 10 days later. According to Pfizer's clinical trials, around 5% of those who received the vaccine became infected with the coronavirus, though none of those infected became seriously ill. While social media networks are flooded with baseless information on the safety of the vaccine, reality tells us otherwise. With one million doses administered, a relatively small number of allergic reactions requiring medical treatment have been observed. We continue to follow the symptoms reported, a majority of which are very mild and include pain, fever, redness at the injection site, headaches, and lethargy.

Yet we must not assume the pandemic is behind us. The number of cases is on the rise, and hospitals, including Sheba Medical Center at Tel Hashomer, have reopened their coronavirus wards.

Now, more than ever, we must avoid corona complacency. We still don't know whether those who received the vaccine can infect others. There are vaccines, like the polio vaccine, that trigger an immune response but do not prevent the virus from multiplying in mucus and infecting others.

With the war on the coronavirus at its height, now is the time for solidarity and both societal and individual responsibility, and for us to continue to wear masks and practice good hygiene and social distancing. I believe that at the start of a new year, there is room for optimism. I hope that we will soon see a return to the normal lives we all miss so much.

Subscribe to Israel Hayom's daily newsletter and never miss our top stories!

 

 

 

 

 

 

 

 

Related Posts